StockTrendNews (STN) Exclusive:Alseres Pharmaceuticals, Inc.
x
EBITDA for Boston Life Sciences Reaches Five Year High
Stock Quote:(N/A:ALSE)
09/02/2009
0.00
N/A
N/A
0
EBITDA for Boston Life Sciences Reaches Five Year High
Last
Price Change
% Chg
Volume
New York, NY, September 2, 2009-EbitdaEXTRA reports that negative EBITDA for Boston Life Sciences, Inc. (NASDAQ:ALSE) for its quarter ended June 30, 2009 was $(1,965,260), a 65% improvement over the y ... read full story
Stocks closed the session mixed as investors weighed new reforms out of Washington, concerns in China and sovereign credit risk warnings. Investors will await comments out of the Fed meeting on Tuesday. A stronger dollar helped to hold the indices in ... read full story
N/A 
